pGL3 Control Vector Citations (3)
Originally described in: Promega Luciferase PlasmidsUnpublished
Articles Citing pGL3 Control Vector
| Articles |
|---|
| Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures. Furusawa Y, Kiso M, Uraki R, Sakai-Tagawa Y, Nagai H, Koga M, Kashima Y, Hojo M, Iwamoto N, Iwatsuki-Horimoto K, Ohmagari N, Suzuki Y, Yotsuyanagi H, Halfmann PJ, Kamitani W, Yamayoshi S, Kawaoka Y. J Virol. 2025 Mar 18;99(3):e0221724. doi: 10.1128/jvi.02217-24. Epub 2025 Feb 12. PubMed |
| Antagonistic roles for MITF and TFE3 in melanoma plasticity. Chang J, Campbell-Hanson KR, Vanneste M, Bartschat NI, Nagel R, Arnadottir AK, Vu HN, Montgomery C, Yevdash J, Jiang J, Bhinu A, Helverson A, Henry MD, Steingrimsson E, Weigel RJ, Cornell RA, Kenny C. Cell Rep. 2025 Apr 22;44(4):115474. doi: 10.1016/j.celrep.2025.115474. Epub 2025 Mar 25. PubMed |
| The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14. Furusawa Y, Iwatsuki-Horimoto K, Yamayoshi S, Kawaoka Y. J Virol. 2025 Jun 17;99(6):e0065625. doi: 10.1128/jvi.00656-25. Epub 2025 May 13. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.